ArTS Archivio della ricerca di Trieste

CANDIDO, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.287
EU - Europa 2.195
AS - Asia 1.299
SA - Sud America 80
AF - Africa 23
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 10
Totale 8.914
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.242
PL - Polonia 577
IT - Italia 453
CN - Cina 400
SE - Svezia 397
SG - Singapore 354
UA - Ucraina 291
HK - Hong Kong 252
FI - Finlandia 120
TR - Turchia 105
GB - Regno Unito 62
BG - Bulgaria 56
DE - Germania 56
IE - Irlanda 55
KR - Corea 37
IN - India 34
BR - Brasile 26
FR - Francia 25
BE - Belgio 21
CA - Canada 20
MX - Messico 18
AU - Australia 17
PK - Pakistan 17
TW - Taiwan 16
JP - Giappone 15
EC - Ecuador 14
CZ - Repubblica Ceca 13
RU - Federazione Russa 13
CO - Colombia 12
EG - Egitto 12
CH - Svizzera 11
PE - Perù 11
TH - Thailandia 11
ES - Italia 10
ID - Indonesia 10
AR - Argentina 9
EU - Europa 9
VN - Vietnam 9
SN - Senegal 8
CL - Cile 7
HR - Croazia 7
IR - Iran 7
NL - Olanda 7
LB - Libano 5
CY - Cipro 4
GR - Grecia 4
IQ - Iraq 4
LU - Lussemburgo 4
NI - Nicaragua 4
AT - Austria 3
CR - Costa Rica 3
DK - Danimarca 3
MY - Malesia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
IL - Israele 2
JO - Giordania 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
DZ - Algeria 1
NO - Norvegia 1
SY - Repubblica araba siriana 1
TG - Togo 1
ZA - Sudafrica 1
Totale 8.914
Salva come PNG Salva come JPEG
Città #
Woodbridge 700
Ann Arbor 621
Houston 569
Warsaw 566
Fairfield 526
Chandler 411
Ashburn 349
Singapore 283
Boardman 275
Jacksonville 258
Seattle 257
Hong Kong 250
Wilmington 244
Cambridge 176
Princeton 98
Izmir 89
Beijing 85
Columbus 84
Trieste 82
Dublin 52
Sofia 52
Dearborn 40
Milan 30
San Diego 29
Helsinki 26
Shanghai 26
Rome 24
Brussels 21
Jinan 21
Seoul 19
Santa Clara 17
Chengdu 16
Dallas 16
Düsseldorf 16
Falls Church 13
Segrate 13
Venice 13
Chicago 11
Phoenix 11
Washington 11
Zhengzhou 11
Brno 10
Nanjing 10
Mestre 9
Padova 9
São Paulo 9
Bengaluru 8
Cairo 8
Dakar 8
Dongguan 8
Kocaeli 8
Lappeenranta 8
Perth 8
Redmond 8
Guangzhou 7
Karachi 7
Messina 7
Munich 7
Naples 7
Pune 7
St. Catharines 7
Venezia 7
Bangkok 6
Bern 6
Cesena 6
Comas 6
Dong Ket 6
Fuzhou 6
Hebei 6
Istanbul 6
Kunming 6
London 6
Los Angeles 6
Manchester 6
Norwalk 6
Quito 6
Suwon 6
Sydney 6
Verona 6
Zagreb 6
Beirut 5
Berlin 5
Bordeaux 5
Cuenca 5
Córdoba 5
Des Moines 5
Lima 5
Lodz 5
Milpa Alta 5
Moscow 5
Shenyang 5
Toronto 5
Zacatecas City 5
Bari 4
Buenos Aires 4
Buffalo 4
Chennai 4
Hualien City 4
Madrid 4
Managua 4
Totale 6.779
Salva come PNG Salva come JPEG
Nome #
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease 347
A new ultrasonographic instrument for measuring vessel wall shear stress. 346
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients 325
Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus. 235
Large-artery hemodynamics after acute alcohol administration in young, healthy volunteers 226
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 196
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 189
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 188
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro 183
TRAIL shows potential cardioprotective activity. 181
Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives 175
Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. 169
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system 167
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation 166
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events 164
Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. 164
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. 163
Strategies used by Patients with Type 1 Diabetes to Avoid Hypoglycemia in a 24×1-Hour Marathon: Comparison with the Amounts of Carbohydrates Estimated by a Customizable Algorithm 160
DOSE AND TIME-DEPENDENT APOPTOTIC EFFECTS BY ANGIOTENSIN II INFUSION ON LEFT VENTRICULAR CARDIOMYOCYTES. 157
Mechanics of the carotid artery wall and baroreflex sensitivity after acute ethanol administration in young healthy volunteers 153
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 149
ACE2 deficiency shifts energy metabolism towards glucose utilization 147
Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension 146
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 144
Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB 142
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 139
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 138
Comparative effects of antihypertensive and/or antioxidative treatment in an experimental model of chronic progressive nephrosis 137
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats 136
Endothelial dysfunction (ED) in familial hypercholesterolemia (FH). Role of the LDL-cholesterol (LDL) variations after LDL-aphaeresis (LDL-A) vs medical therapy 136
Contribution of Systemic Blood-pressure To Myocardial Remodeling In Uremic Rats 133
Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers. 133
Haemoconcentration, shear-stress elevation and carotid artery diameter regulation after furosemide in older hypertensives 132
Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? 128
Modulation of cardiac apoptosis by estrogen and ACE inhibition in ovariectomized spontaneously hypertensive rats 127
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 127
Effects of central alpha 2-adrenergic agonists on systemic haemodynamics and on baroreceptor reflex sensitivity in spontaneously hypertensive rats. 121
Hypertension and diabetes: emphasis on the renin-angiotensin system in atherosclerosis 120
Regional and systemic haemodynamic response to aortography in hypertensives. 119
Linking diabetes and atherosclerosis 118
Angiotensin II promotes apoptosis in ventricular cardiomyoctes in vivo 104
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials. 101
In vivo effects of fluvastatin on leukocyte vascular trafficking under experimental acute inflammatory conditions 98
Endothelium vasomotor function after LDL-apheresis in patients with familial hypercolesterolemia 89
Treatment for diabetic nephropathy - a review of the recent patent literature 89
Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypotensive and subhypotensive doses of an ACE inhibitor 86
Modulation of glomerular albumin permeability by angiotensin II infusion and effects of angiotensin type 1 receptor blockade 82
Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials 81
Forearm endothelial dysfuncion (ED) is a marker of the epato-renal vascular impairment but not of the systemic haemodynamic control in cirrhotic patients 80
Large artery mechanics after bladder neck obstruction in SHR rats 79
Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells 70
Personalized Approach for the Management of Exercise-Related Glycemic Imbalances in Type 1 Diabetes: Comparison with Reference Method 69
Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents 56
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 54
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 54
Italian guidelines for the treatment of type 2 diabetes 54
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 47
Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: a retrospective cohort study 46
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials. 40
Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice 38
Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group 36
Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression 36
An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience 35
Safety and Appropriateness in the Management of the Treatment Pathway of Pregnant Women with Gestational Diabetes 35
L'enzima di conversione dell'angiotensina 2 regola il metabolismo glucidico 31
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population 30
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 28
ACE-inhibitor treatment prevents cardiac remodelling in experimental uremia 27
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study 26
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 26
Sinergia collaborativa nella gestione del paziente diabetico con recente sindrome coronarica acuta 25
La territorializzazione del farmaco in epoca di PNRR: prospettive, opportunità e spunti di riflessione da un panel di esperti 25
2023 update on Italian guidelines for the treatment of type 2 diabetes 24
The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care 24
Italian guidelines for the treatment of type 2 diabetes 24
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey 24
Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies 23
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products 22
AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care 22
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus 22
A new ultrasonographic instrument for measuring vessel wall shear stress: Comparison to a mathematical model in essential hypertensives 22
Digital technology and healthcare delivery in insulin-treated adults with diabetes: a proposal for analysis of self-monitoring blood glucose patterns using a dedicated platform 21
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis 21
ACE inhibitors (ACEI) prevent an early albumin permeability defect in isolated glomeruli from streptozotocin-treated rats 20
Clinical Inertia Is the Enemy of Therapeutic Success in the Management of Diabetes and Its Complications: A Narrative Literature Review 20
ACE inhibitor treatment prevents cardiac programmed cell death and intermyocardiocytic fibrosis in hypertensive diabetic rats 20
A new ultrasonographic instrument for measuring vessel wall shear stress: comparison to a mathematical model in essential hypertensives 20
Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes 19
Disfunzione diastolica e diabete 17
Ace Inhibitor treatment prevents renal growth and hyperfiltration in streptozotocin diabetic rats 16
Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications 15
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study 15
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes 15
ACE inhibitors (ACEI) prevent an early albumin permeability defect in isolated glomeruli from streptozotocin-treated rats 15
Acarbose vs metformin for new-onset type 2 diabetes 14
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 14
Aminoguanidine ameliorates diabetes-associated atherosclerosis in apolipoprotein-E KO mice 14
Disfunzione endoteliale: obiettivo terapeutico primario nel diabete 13
Ruolo di liraglutide nella cura dei pazienti con diabete tipo 2: l'esperienza regionale del Friuli Venezia Giulia 13
A transparent machine learning algorithm uncovers HbA1c patterns associated with therapeutic inertia in patients with type 2 diabetes and failure of metformin monotherapy 12
Totale 9.024
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.211 0 0 0 0 112 267 157 197 178 167 86 47
2020/2021853 83 67 57 116 56 89 49 70 37 116 34 79
2021/2022631 24 36 24 58 21 57 32 17 71 67 54 170
2022/20231.120 87 126 99 146 113 207 3 108 155 15 46 15
2023/20241.332 47 233 74 57 109 86 201 148 23 27 157 170
2024/20251.175 128 125 206 240 476 0 0 0 0 0 0 0
Totale 9.296